Ade Deane-Pratt

Researchers have shown that a new drug treatment for cystic fibrosis and Duchenne muscular dystrophy can override a genetic fault that causes choroideremia.

Find out what’s in the autumn 2016 awards

Researchers at the University of Bath are developing a test for a complication of childhood arthritis that affects the eye

RP Genome Project research discovers 6 faults in the REEP6 gene that affect families in the UK and USA.

High-fat diet leads to inflammation throughout the body and can prompt unhealthy new blood vessel growth in the eye

Fight for Sight and Thomas Pocklington Trust form new partnership to fund vision research

Fight for Sight and National Eye Research Centre partner to co-fund two new studies

Researchers aim to protect the optic nerve instead of lowering eye pressure

The award is part of the Clearly campaign for better eye care

New research funding partnership between Fight for Sight and Birdshot Uveitis Society

Researchers discover a new type of communication between donor photoreceptors developed from stem cells and host photoreceptors in mice with retinal dystrophy

Researchers think it could become an alternative to existing treatments

The Ophthalmologist magazine has a great feature on the world’s first robot-assisted eye surgery

An AMRC infographic on the impact medical research charities have on the UK research environment.

The award-winning researcher's work on cell recycling is vital for understanding sight loss

Aflibercept can now be used as the first choice for NHS treatment in macular oedema due to branch retinal vein occlusion

NIHR report finds 130 upcoming technologies and procedures

Dr Lengyel and Dr Stewart give a 2-minute summary of their research into a hallmark sign of age-related macular degeneration

Fight for Sight researcher Dr Alex Shortt's quick video summaries of the meeting between industry and top clinicians on the future of treatments for the eye and sight loss.

The PRECEYES system is in use at Oxford’s John Radcliffe Hospital

Dr Shyamanga Borooah takes the 5th annual award from the prestigious USA-UK partnership for eye research

Fight for Sight teams up with the Scottish government’s Chief Science Office

A common variation in the microRNA gene miR-182 is linked to primary open angle glaucoma

Disulfiram prevents scars forming in a mouse model of scarring conjunctivitis and returns human scarring cells from people with the condition back to normal

Adalimumab is the first ‘biologic’ drug licensed to treat some types of non-infectious inflammation in the middle part of the eye

Researchers in the USA show that the eye’s drainage system can be repaired

Small USA study shows minor surgery improves vision for 3 in 4 treatments

A major step forward for optic nerve regeneration research

One million digital eye scans will be analysed using artificial intelligence

Spotlight on research into conditions that affect the macula during Macula Week 2016.

Spotlight on retinitis pigmentosa during Deafblind Awareness Week 2016

Healthcare workers and eye service decision-makers also give positive reviews for the smartphone suite

Results from two Fight for PhD students take us closer to developing treatment to prevent blindness from a widespread tropical condition

Dr Keenan gives a 1-minute summary of his research on a genetic fault that increases the risk of getting age-related macular degeneration.

Developing new tests for detecting and monitoring glaucoma and understanding the condition in it rare and most common forms

But the good news is that they may be better at preventing future sight loss than existing glaucoma treatments.

We’re looking for patients, relatives and carers of people with corneal conditions to join a 2-hour focus group in London on 27 May.

Encouraging results from a 3.5-year follow up to the Phase I clinical trial

A new focus for AMD drug target could reduce the need for millions of follow-up eye operations

World-renowned glaucoma surgeon voted member of The 2016 Power List

Fight for Sight-funded scientists successfully test new potential treatment for severe inherited childhood sight loss

Join the United Kingdom Eye Survey as a lay member of the Board

Fight for Sight researchers design an eye chart that could lead to earlier diagnosis for millions of people

A round-up of what we know about a popular ‘drug’ that may be linked to sight loss

Fight for Sight has awarded a new round of grants for eye research.

Research points to a potentially safer way to stop sight-threatening blood vessels growing in the eye

#WorldGlaucomaWeek: Fight for Sight researchers develop a new tool that could make it easier to develop new treatments

A new cataract surgery technique could mean the end of artificial lenses and researchers take a first step towards growing new eyes

A World Glaucoma Week round-up of recent advances in glaucoma research from Fight for Sight scientists

NightstaRx and the University of Oxford team-up with Dutch technology company

Scientists have identified a key cause of damage to the cornea in Meesmann epithelial corneal dystrophy.

Chlamydia can exchange genes between sites of infection

Aiming to understand why the effects of brief infections are so long-lasting in the world’s leading infectious cause of blindness

Differences in the way the body uses vitamin B1 affect the risk of complications from diabetes

A look behind the headlines at reports that cholesterol-lowering statins improve vision

A 'revolutionary' new tool that’s also showing promise in X-linked RP and corneal dystrophy research.

A step towards treatment that could end the need for transplant surgery

Researchers are taking note of the Sight Loss and Vision Priority Setting Partnership

Results part-funded by Fight for Sight suggest new targets for screening, prevention and treatment.

New genes discovered in a study that will improve the way future research is done.

12 months and some really exciting steps forward

The results are a vital step towards gene therapy for a cause of severe sight loss in young children. We co-funded the research together with RP Fighting Blindness.

Results in adults with normal vision point to a possible future treatment for adults with 'lazy eye'

Spotlight on inherited eye disorders, AMD, glaucoma and corneal blindness

Fight for Sight’s Small Grant Award Schemes for 2015 have funded 21 new research projects at a cost of £0.3 million.

Problems looking at patterns might help diagnose the condition also known as chronic fatigue syndrome (CFS)

The treatment could become an important part of preventing sigh loss worldwide

A new approach that might help the people who don't respond to standard treatment.

A study of millions of health records shows levodopa delays or prevents a major cause of sight loss.

NightstaRx secures investment from venture capital firm New Enterprise Associates

How close are we to developing a non-surgical treatment for cataract?

Promising research in animals and human tissue on developing non-surgical treatment.

Results from the study suggest treatment can preserve useful vision for at least 2 years.

A discovery that might one day lead to preventing sight loss from age-related macular degeneration.

Dr Harry Orlans will work at the University of Oxford to develop a treatment for dominant retinitis pigmentosa.

The treatment restored vision to mice with the most common genetic fault to cause the condition in humans.

A look at some potential ways to improve vision in AMD and after eye cancer and at new technology to correct refractive error.

Researchers at Great Ormond Street are studying ‘cerebral visual impairment’.

The first ever Funders of Eye Research Summit (FundERS 2015) was created in association with Fight for Sight.

A 60-year-old woman has become the world’s first person to have an experimental stem cell treatment for age-related macular degeneration.

A joint statement calls for a broad and inclusive discussion about the future implications.

New 'wide-field' imaging can see more of the retina and reveal who is most at risk.

Focus on: diabetic retinopathy

Promising pre-clinical research shows that lanosterol can turn cloudy lenses clear

A review of new and emerging technologies highlights some really important concerns that come directly from patients.

Fight for Sight results published in Molecular Therapy show that the cells could drive visually-guided behaviour, even in late stage disease.

Microglia could make a new target for treatment to slow sight loss.

Biopharmaceutical company Nightstar announces new study at the University of Alberta.

UK and Italian researchers have discovered the genetic cause of a rare form of blindness, in a project co-funded by Fight for Sight.

A look at our diabetic retinopathy research for Diabetes Week.

The projects will take place at top UK institutions in Belfast, London, St Andrews, Edinburgh, Cardiff and Durham.

International research team discovers unexpected role for ATF6 in vision.

Study shows the Peek Acuity app is as fast and accurate as using standard eye charts.

RP Genome Project research reveals that the gene DRAM2 is essential for vision.

Young people of European ancestry are more likely to be short-sighted than older generations.

USA’s National Foundation for Eye Research recognises Dr Michael Wormstone's significant scientific work on the lens

Final results from the first clinical trial of gene therapy for Leber congenital amaurosis.

Dinitrophenol (DNP) linked to serious side-effects including fast-forming cataracts and glaucoma.

Results from a pre-clinical study show that a single injection lead to benefits lasting '16 human years'.

Faults in PNPLA6 lead to the death of light-sensitive cells in the eye.

The process of scarring in the retina after photoreceptor loss varies on the genetic fault behind the condition.

New study finds it's better to start treatment when sight test scores are under 6/12

The results are part of Fight for Sight's REGARD programme to build an optimal, patient-led model of care services.

A study at hospitals across the UK to compare currently available NHS tests to the 'gold standard' diagnostic test.

UK and USA regulators approve the incentive to develop treatments for rare conditions

Fight for Sight has awarded seven new PhD studentships in eye research for 2015.

Teeth may be a good source of cells to repair the eye and restore sight.

Researchers at the University of Pennsylvania are to begin the first US clinical trial of gene therapy for choroideremia

Syncona LLP increases its investment in independent pharmaceutical Nightstar to £17 million

We partner with Thomas Pocklington Trust to co-fund research into a little-known aspect of this disabling, long-term condition.

A mineral found in teeth and bones is identified in the macula for the first time.

Fight for Sight and British Thyroid Foundation partner to co-fund new research

Indiegogo appeal to raise extra funds for Peek to be manufactured and delivered globally

Contact lens manufacturer adds 'No water’ campaign message to their packaging to raise awareness of Acanthamoeba keratitis – a serious, sight-threatening eye infection.

Fight for Sight researchers publish proof-of-principle study that could lead to new tests for glaucoma and other sight loss conditions.